Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 14 symbols : Snynf save search
$72.6 Billion Worldwide Biotech Ingredients Industry to 2027 - Featuring AbbVie Advanced Biotech and Amyris Among Others
Published: 2022-07-14 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.79%
H: 2.41%
C: 0.26%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.96%
H: 0.35%
C: 0.25%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -2.18%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: -1.42%
H: 0.14%
C: -1.32%
biotech
Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData PlcRoche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years
Published: 2022-07-14 (Crawled : 15:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
drug cancer market
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis
Published: 2022-07-14 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
dupixent sanofi
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic E...
Published: 2022-07-14 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
dupixent sanofi
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
Published: 2022-07-14 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -1.0%
H: 1.64%
C: 0.48%
dupixent children trial positive results
Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData Plc
Published: 2022-07-14 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
cancer market
Dupixent® (dupilumab) Phase 3 Trial Shows Positive Results in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Regeneron Pharmaceuticals, Inc. and Sanofi announced that a Phase 3 trial asses...
Published: 2022-07-14 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -1.0%
H: 1.64%
C: 0.48%
dupixent children trial positive results sanofi phase 3
Dupixent® (dupilumab) Phase 3 Trial Shows Positive Results in Children 1 to 11 Years of Age with Eosinophilic Esophagitis
Published: 2022-07-14 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.09%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -1.0%
H: 1.64%
C: 0.48%
dupixent children trial positive results phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.